On February 10, 2026, Equilab International and UGM Academic Hospital or also known as Rumah Sakit Akademik Universitas Gadjah Mada (RSA UGM) signed a clinical trial agreement to strengthen clinical trial projects in Indonesia. The agreement was signed by Ronal Simanjuntak, President Director of Equilab International, and Dr. dr. Darwito, S.H., Sp.B(K)On, Director of RSA UGM. This partnership is designed to combine academic clinical excellence with professional study manageme

Equilab International, as a leading Contract Research Organization (CRO) in Indonesia and Southeast Asia, specialized in bioequivalence studies, clinical trial, laboratory testing, and dermatology testing, is proud to be featured in a peer-reviewed article of the Bulletin of the World Health Organization (WHO), one of the world’s most respected global public health journals. The article highlights Equilab’s contribution in scientific laboratory work to support accurate regula

Jakarta, 29 Januari 2026 – Equilab International sebagai laboratorium pengujian produk-produk  farmasi, kosmetik, dan pangan, kembali mengukuhkan posisinya sebagai mitra strategis industri dengan meraih Rekognisi Maturitas Tingkat 4 dari Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia. Pencapaian ini merupakan standar tertinggi yang diberikan BPOM kepada laboratorium eksternal pengujian produk. Penghargaan diberikan langsung oleh Kepala BPOM RI, Prof. dr. Taruna Ikr

To strengthen Indonesia's position in the global research ecosystem, Equilab International as the Indonesian Contract Research Organization (CRO), has formalized the first strategic collaboration with the Clinical Research Unit (CRU) in National Brain Center Hospital (also known well as RS PON). This partnership synergizes the clinical operations capabilities and advanced laboratory analysis of both institutions to facilitate high-quality clinical research in Indonesia. For t

Equilab International recently took a role as a featured speaker at the RSUD Dr. Soetomo Research Hub 2025 event in Surabaya. The event held under the theme, “Build Hospital Reputation through Research.” The forum convened leading stakeholders from hospitals in East Java, the Ministry of Health (MoH), the National Agency of Drug and Food Control (BPOM), researchers, contract research organizations (CROs), and the pharmaceutical industries. The core discussion focused on strat

As a leading Bioequivalence Centre in Indonesia and Southeast Asia, Equilab International was honored to be one of the speakers at the Asia Pacific Pharma Executive Forum 2025, held in Nusa Dua, Bali, on October 15–16, 2025. Equilab’s Group Analytical Manager, Mr. Yantirta Indra Kurniawan, S.Si, M.Biomed, shared a presentation on “The Critical Role of the Bioanalytical Aspect in Drug Development” to participants from South East Asian countries, India, Japan, Korea, Australia,

Jakarta, 22 Oktober 2025 – Asosiasi Pengusaha Suplemen Kesehatan Indonesia (APSKI) melakukan kunjungan resmi ke Equilab International sebagai laboratorium pengujian di Indonesia  dalam rangka memperkuat sinergi di bidang pengujian suplemen, obat tradisional, dan produk kosmetik. Kunjungan ini menjadi langkah awal untuk kolaborasi yang mencakup uji klinis, laboratory testing , hingga dermatology testing , sebagai upaya meningkatkan standar mutu dan keamanan produk kesehatan di

Surabaya, 1 Oktober 2025  – Equilab International sebagai laboratorium pengujian kosmetik di Indonesia yang sudah terakreditasi ISO 17025...

Thank you for the trust from all of our customers, we are glad to announce that Equilab International is now listed in the "Top...

In a significant step toward advancing Indonesia's bioequivalence and clinical trial landscape, dr. William Adi Teja, MD, B.Med., M.Med....

Equilab International sebagai laboratorium pengujian di Indonesia yang sudah terakreditasi KAN ISO 17025 berpartisipasi turut hadir dalam...

In a continued effort to strengthen Indonesia’s clinical trial ecosystem, the Material Transfer Agreement (MTA) Committee of Indonesia's...